[Congressional Bills 115th Congress]
[From the U.S. Government Publishing Office]
[H.R. 5219 Introduced in House (IH)]

<DOC>






115th CONGRESS
  2d Session
                                H. R. 5219

 To require sellers of opioids at retail to verify the identity of the 
prospective purchaser and enter certain information about the purchase 
 into the respective State's prescription drug monitoring system, and 
                          for other purposes.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                             March 8, 2018

 Mr. Rodney Davis of Illinois introduced the following bill; which was 
            referred to the Committee on Energy and Commerce

_______________________________________________________________________

                                 A BILL


 
 To require sellers of opioids at retail to verify the identity of the 
prospective purchaser and enter certain information about the purchase 
 into the respective State's prescription drug monitoring system, and 
                          for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Opioid Prescription Verification Act 
of 2018''.

SEC. 2. REQUIREMENTS FOR RETAIL SALE OF OPIOIDS.

    (a) In General.--In any State that maintains a prescription drug 
monitoring system, each regulated seller (as defined in section 102 of 
the Controlled Substances Act (21 U.S.C. 802)) shall ensure that sales 
by such seller of an opioid at retail are made in accordance with the 
following:
            (1) The seller verifies the identity of the prospective 
        purchaser by requiring the prospective purchaser to present--
                    (A) an identification card that provides a 
                photograph and is issued by a State or the Federal 
                Government; or
                    (B) a document that, with respect to 
                identification, is considered acceptable for purposes 
                of sections 274a.2(b)(1)(v)(A) and 274a.2(b)(1)(v)(B) 
                of title 8, Code of Federal Regulations (as in effect 
                on or after March 9, 2006).
            (2) The seller enters into the State's prescription drug 
        monitoring system, at a minimum, the following information:
                    (A) The name of the opioid.
                    (B) The quantity sold.
                    (C) The name and address of the purchaser.
                    (D) The name and address of the patient for whom 
                the opioid is prescribed.
                    (E) The date and approximate time of the sale.
    (b) Delayed Applicability.--Subsection (a) applies to the sale of 
opioids at retail beginning on the date that is 6 months after the date 
of enactment of this Act.
                                 <all>